Human pancreatic islet 3D chromatin architecture provides insights into the genetics of type 2 diabetes

2018 ◽  
Author(s):  
Carmen Adriaens
2019 ◽  
Vol 51 (7) ◽  
pp. 1137-1148 ◽  
Author(s):  
Irene Miguel-Escalada ◽  
Silvia Bonàs-Guarch ◽  
Inês Cebola ◽  
Joan Ponsa-Cobas ◽  
Julen Mendieta-Esteban ◽  
...  

Author(s):  
Leonore Wigger ◽  
Marko Barovic ◽  
Andreas-David Brunner ◽  
Flavia Marzetta ◽  
Eyke Schöniger ◽  
...  

eLife ◽  
2018 ◽  
Vol 7 ◽  
Author(s):  
Matthias Thurner ◽  
Martijn van de Bunt ◽  
Jason M Torres ◽  
Anubha Mahajan ◽  
Vibe Nylander ◽  
...  

Human genetic studies have emphasised the dominant contribution of pancreatic islet dysfunction to development of Type 2 Diabetes (T2D). However, limited annotation of the islet epigenome has constrained efforts to define the molecular mechanisms mediating the, largely regulatory, signals revealed by Genome-Wide Association Studies (GWAS). We characterised patterns of chromatin accessibility (ATAC-seq, n = 17) and DNA methylation (whole-genome bisulphite sequencing, n = 10) in human islets, generating high-resolution chromatin state maps through integration with established ChIP-seq marks. We found enrichment of GWAS signals for T2D and fasting glucose was concentrated in subsets of islet enhancers characterised by open chromatin and hypomethylation, with the former annotation predominant. At several loci (including CDC123, ADCY5, KLHDC5) the combination of fine-mapping genetic data and chromatin state enrichment maps, supplemented by allelic imbalance in chromatin accessibility pinpointed likely causal variants. The combination of increasingly-precise genetic and islet epigenomic information accelerates definition of causal mechanisms implicated in T2D pathogenesis.


2019 ◽  
Vol 10 (1) ◽  
Author(s):  
William W. Greenwald ◽  
Joshua Chiou ◽  
Jian Yan ◽  
Yunjiang Qiu ◽  
Ning Dai ◽  
...  

2014 ◽  
Vol 92 (4) ◽  
pp. 314-323 ◽  
Author(s):  
Clara Westwell‐Roper ◽  
Dominika Nackiewicz ◽  
Meixia Dan ◽  
Jan A Ehses

2012 ◽  
Vol 444 (2) ◽  
pp. 239-247 ◽  
Author(s):  
Ling Yan ◽  
Shuangli Guo ◽  
Marie Brault ◽  
Jamie Harmon ◽  
R. Paul Robertson ◽  
...  

The FOXO1 (forkhead box O1) transcription factor influences many key cellular processes, including those important in metabolism, proliferation and cell death. Reversible phosphorylation of FOXO1 at Thr24 and Ser256 regulates its subcellular localization, with phosphorylation promoting cytoplasmic localization, whereas dephosphorylation triggers nuclear import and transcriptional activation. In the present study, we used biochemical and molecular approaches to isolate and link the serine/threonine PP2A (protein phosphatase 2A) holoenzyme containing the B55α regulatory subunit, with nuclear import of FOXO1 in pancreatic islet β-cells under oxidative stress, a condition associated with cellular dysfunction in Type 2 diabetes. The mechanism of FOXO1 dephosphorylation and nuclear translocation was investigated in pancreatic islet INS-1 and βTC-3 cell lines subjected to oxidative stress. A combined chemical cross-linking and MS strategy revealed the association of FOXO1 with a PP2A holoenzyme composed of the catalytic C, structural A and B55α regulatory subunits. Knockdown of B55α in INS-1 cells reduced FOXO1 dephosphorylation, inhibited FOXO1 nuclear translocation and attenuated oxidative stress-induced cell death. Furthermore, both B55α and nuclear FOXO1 levels were increased under hyperglycaemic conditions in db/db mouse islets, an animal model of Type 2 diabetes. We conclude that B55α-containing PP2A is a key regulator of FOXO1 activity in vivo.


Sign in / Sign up

Export Citation Format

Share Document